Holen Sie sich die Stockscreener-App
2.07
0.00%
0.00
Handel nachbörslich:
2.14
0.07
+3.38%
Schlusskurs vom Vortag:
$2.07
Offen:
$2.07
24-Stunden-Volumen:
33,024
Relative Volume:
0.72
Marktkapitalisierung:
$46.92M
Einnahmen:
$35.16M
Nettoeinkommen (Verlust:
$-11.44M
KGV:
-3.4726
EPS:
-0.5961
Netto-Cashflow:
$-15.44M
1W Leistung:
-19.14%
1M Leistung:
-25.81%
6M Leistung:
-56.60%
1J Leistung:
-77.54%
1-Tages-Spanne:
$2.02
$2.155
1-Wochen-Bereich:
$2.01
$2.62
52-Wochen-Spanne:
$1.82
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Firmenname
Bioharvest Sciences Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare BHST vs JBS, KHC, GIS, MKC, HRL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
2.07 | 48.74M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
13.65 | 43.16B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
25.51 | 29.09B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
39.20 | 20.38B | 18.42B | -85.30M | 1.63B | -0.1894 |
MKC
Mccormick Co Inc
|
54.67 | 14.24B | 7.39B | 1.63B | 1.02B | 6.0085 |
HRL
Hormel Foods Corp
|
24.54 | 13.42B | 12.22B | 466.64M | 692.94M | 0.8477 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Roth Capital | Buy |
| 2025-05-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-18 | Eingeleitet | Maxim Group | Buy |
Bioharvest Sciences Inc Aktie (BHST) Neueste Nachrichten
BioHarvest Sciences Inc. Common Stock (NASDAQ: BHST) Stock Price, News & Analysis - Kalkine
BioHarvest Sciences Inc. (NASDAQ:BHST) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
BHST Maintains Rating by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
BHST Maintained by Roth Capital -- Price Target Lowered to $8.00 - GuruFocus
BioHarvest at canaccord growth conference: scaling plant-cell platform By Investing.com - Investing.com Canada
BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability - TradingView
BioHarvest at canaccord growth conference: scaling plant-cell platform - Investing.com
BioHarvest Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript - AOL.com
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlight - GuruFocus
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ... - Yahoo Finance
What Could BioHarvest Sciences (NASDAQ:BHST) Quarterly Update Show? - Kalkine Media
What Will BioHarvest Sciences (NASDAQ:BHST) Add to Nasdaq Focus? - Kalkine Media
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss By Investing.com - Investing.com Canada
What Is BioHarvest Sciences (NASDAQ:BHST) Nasdaq Composite Focus? - Kalkine Media
BioHarvest Sciences cuts FY26 sales guidance to $37-40 million - scanx.trade
Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
BioHarvest Sciences Q2 Earnings Call Highlights - marketbeat.com
BioHarvest Sciences: Secured first major CDMO contract and reaffirmed 2027 EBITDA breakeven despite revised 2026 guidance - TradingView
BioHarvest Sciences: Secured a transformative fragrance CDMO contract, driving revenue growth and 2027 EBITDA breakeven - TradingView
Earnings call transcript: BioHarvest Sciences posts smaller Q2 2026 loss - Investing.com
BioHarvest Sciences shares surge 11% after major fragrance manufacturing deal - Yahoo Finance
BioHarvest Sciences shares surge 11% on major fragrance deal By Investing.com - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
BioHarvest secures fragrance manufacturing deal worth $20-30M By Investing.com - Investing.com Australia
BioHarvest secures first CDMO manufacturing dea... - pluang.com
BioHarvest Sciences shares surge 11% on major fragrance deal - Investing.com
BioHarvest Sciences: Q2 revenue up 3.8% to $8.8M; first CDMO deal signed; full-year guidance revised downward - TradingView
BioHarvest secures fragrance manufacturing deal worth $20-30M - Investing.com
BioHarvest Sciences Announces Q2 2026 Financial Results and Secures Inaugural CDMO Fragrance Manufacturing Contract for 20-Ton Production - Kalkine Media
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioHarvest Sciences Lands Exclusive 20-Tonne Rare Fragrance Production Deal Worth $20–$30 Million - Kalkine Media
BioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compound - Proactive financial news
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - 富途牛牛
BioHarvest Sciences (BHST) Holds Steady at $2.26, Trapped Between $2.15 Support and $2.37 ResistanceRetail Volume - dars.gov.et
Enterprise value to EBIT forward of BioHarvest Sciences, Inc. – FWB:8MV0 - TradingView
Pivot Bio to Honor 15 Under 20 Global Fields of Promise Fellows - AOL.com
Price to sales forward of BioHarvest Sciences, Inc. – MUN:8MV0 - tradingview.com
BioHarvest Sciences CEO to Present at Canaccord Genuity 46th Annual Growth Conference in Boston - kalkine.ca
BioHarvest Sciences CEO to present at Canaccord Genuity conference - Proactive financial news
BioHarvest Sciences to Unveil Q2 2026 Financial Results on August 11, 2026 - Kalkine Media
BioHarvest CEO to discuss first 100 days and 2026 growth plan - Stock Titan
BioHarvest to report Q2 2026 earnings and host a conference call on August 11 - Pluang
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioharvest Sciences Inc (BHST) Balance Sheet - TradingKey
Bioharvest Sciences Inc (BHST) Cash Flow - TradingKey
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioHarvest Sciences, Inc. Revenue Breakdown – LSX:A40C6G - TradingView
Finanzdaten der Bioharvest Sciences Inc-Aktie (BHST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):